Activation of the Human Transient Receptor Potential Vanilloid Subtype 1 by Essential Oils

    January 2010 in “ Biological & pharmaceutical bulletin ”
    Susumu Ohkawara, Toshiko Tanaka‐Kagawa, Yôko Furukawa, Tetsuji Nishimura, Hideto Jinno
    Image of study
    TLDR Certain essential oils can activate a human skin receptor, potentially helping with skin disorders.
    The study investigated the activation of the human Transient Receptor Potential Vanilloid Subtype 1 (TRPV1) by essential oils using human TRPV1-expressing HEK293 cells. Out of 31 essential oils screened, four (rose, thyme geraniol, palmarosa, and tolu balsam) activated TRPV1. Citronellol and geraniol, the main constituents of some of these oils, were identified as new human TRPV1 agonists. The study provided a scientific basis for the use of certain essential oils in activating TRPV1, which could have therapeutic implications for skin disorders. Further detailed studies were recommended to understand their structure and physiological functions.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 42 results

      community Physician here AMA – 30M oral Fin 1-1.25 mg daily

      in Update  47 upvotes 2 years ago
      Hair loss treatments, specifically the use of finasteride, microneedling and potentially oral minoxidil. People discussed their experiences with finasteride, its effects on sexual behaviors, as well as potential solutions such as tadalafil or using other growth factor signal peptides for hope in curing male pattern baldness.

      community Creatine's effect on Hair Loss and DHT

      in Research/Science  98 upvotes 8 months ago
      A 21-year-old male managed to control his hair loss using Nizoral, RU58841, and finasteride, but experienced increased scalp itchiness after starting creatine, which subsided upon stopping creatine. Users shared mixed experiences on whether creatine affects hair loss, with some reporting negative effects and others seeing no change or defending its benefits.

      community PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance

      in Research/Science  123 upvotes 11 months ago
      The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

      community Pyrilutamide just launched internationally, and all you're doing is hating

      in Product 3 months ago
      The post and conversation are about the high cost and skepticism surrounding pyrilutamide as a hair loss treatment, with comparisons to minoxidil, finasteride, and RU58841. The original poster defends pyrilutamide's effectiveness and criticizes others for dismissing it without proper understanding.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  136 upvotes 7 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

    Similar Research

    5 / 1000+ results